Follow
Hematology Blood Disorders
Hematology Blood Disorders
Editor
Verified email at peerjournal.org - Homepage
Title
Cited by
Cited by
Year
Eosinopenia as a diagnostic marker in Covid-19
F Ajeneye, O Olofin
Hematol Blood Disord 2020; 2 (1): 31-33. 32 Hematol Blood Disord 2020 Volume …, 2020
22020
Gemcitabine-carbon nitride dots as nanocarrier to target specifically pediatric glioma tumors
PYL Roger M Leblanc*
Hematology and Blood Disorders 3 (2), 33-35, 2020
2020
Hypermanganesemia Revisited
A Zeglam
Hematology and Blood Disorders 3 (1), 25-27, 2020
2020
Reduction of frequency of pain in clinical trial with association of arginine and hydroxyurea in sickle cell anemia's patients in Brazil
REÃÂ rio
Hematology and Blood Disorders 3 (1), 23-24, 2020
2020
Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy
LV Tom van Meerten, Mathilde Rikje Willemijn de Jong
Hematology and Blood Disorders 3 (1), 21-22, 2020
2020
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty.
GG Mingyang Yu, Bowu Luan, Simiao Tian
Hematology and Blood Disorders 1 (1), 6-10, 2017
2017
Next-generation sequencing: emerging technology in the area of hematology and blood disorder.
PS Kedar
Hematology and Blood Disorders 1 (1), 3-4, 2017
2017
Survey of hemoglobinopathies in Central Vietnam: Identification of a novel ?-globin gene mutation (HBB:c.-122T>A)
PM Monica Pirastru, Laura Manca, Chau Quynh Nguyen
Hematology and Blood Disorders 2 (1), 13-15, 2017
2017
Diagnosis of thrombotic thrombocytopenic purpura in low income country applicability of plasmic score.
DS Oliveira
Hematology and Blood Disorders 2 (1), 11-12, 2017
2017
Testicular relapse in Acute Lymphoblastic Leukemia (ALL): A simple problem of common sense
AG Martins
The critical push for traceability compliance: A District General Hospital experience.
F Ajeneye
The system can't perform the operation now. Try again later.
Articles 1–11